Expert Speakers

2023 Speakers

Discover which expert speakers and KOLs are presenting at the  7th Annual Liquid Biopsy for Precision Oncology Summit this February 2023.  

Adam Brown

Global Medical Affairs Lead, Oncology ctDx

Agilent Technologies

Andrea Stevens

Director - Precision Medicine Access Strategy

Janssen

Antje Hoering

President & CEO

Cancer Research & Biostatistics

Brian Baker

Senior Director - Regulatory Affairs & CDx

Regeneron Pharmaceuticals

Carl Barrett

Vice President, Translational Science & Oncology

AstraZeneca

Carl Morrison

Professor Director & Senior Vice President - Molecular Pathology

Roswell Park Comprehensive Cancer Center

Dana Connors

Scientific Program Manager

Cancer Research Partnerships Foundation for the National Institutes of Health

Elizabeth Attias

Chief Strategy and Development Officer

Sermonix Pharmaceuticals

Erin Newburn

Senior Director, Field Applications Scientist

Personalis Inc

Fernando Cruz-Guilloty

Director - Oncology Precision Medicine & Diagnostics

Janssen

George Vasmatzis

Co-Director - Biomarker Discovery Program

Mayo Clinic

Jadwiga Bienkowska

Senior Director & Head of Computational Biology & Oncology Research

Pfizer

JD Schonhoft

Senior Principal Scientist - Translational Medicine

Repare Therapeutics

Jean-Francois Martini

Executive Director - Translational Oncology Lead, Global Product Development – Oncology

Pfizer

Jennifer Skenfield

Director - Clinical Operations, Oncology & Early Development

Gilead

Julien Senac

Global Director, IVD Focus Team & Strategic Account Manager

TÜV SÜD

June Lu

Sr. Director

BeyondSpring Pharmaceuticals Inc.

Kara Bortone

Senior Director

Janssen

Kirk Tanner

CSO and SVP Brain Tumor Investment Fund

National Brain Tumor Society

Lauren Leiman

Executive Director

BloodPAC

Marielena Mata

Senior Director - Diagnostics Lead

Pfizer

Mark Stewart

Vice President, Science Policy

Friends of Cancer Research

Michael Krainock

Medical Director, Oncology

Natera Inc.

Mike Damore

Director - Translational Oncology Lead

Pfizer

Nicholas Gallerani

Scientific Affairs

NuProbe

Nike Beaubier

Senior Vice President

Tempus Labs

Nikki Martin

Senior Director, Precision Medicine Initiatives

LUNGevity

Pashtoon Kasi

Assistant Professor of Medicine

Weill Cornell Medical College

Qu Zhang

Director - Clinical Biomarkers & Immuno-Oncology

GSK

Ranjan J. Perera

Director RNA Centre, Associate Professor

Johns Hopkins School of Medicine

Robert McCormack

Principal

Independent Consultant

Sarah Paul Shagan

Senior Scientific Manager - Biomarker Lead

Genenetch

Shrividya Iyer

Executive Director - Oncology Global Real World Evidence, Health Economics & Outcomes Research

Eisai

Stacey Adam

Associate Vice President - Research Partnerships

Foundation for the National Institutes of Health

Sunanatha Setharuman

Principal Scientist - Clinical Bioinformatics

Repare Therapeutics

Taylor Jensen

Vice President, Head of Oncology Science

LabCorp

Yu Liang

Director - Clinical Biomarker

Compugen

Zhenhao Qi

Director, Global Companion Diagnostics Lead Global Companion Diagnostics Global Oncology R&D

Daiichi Sankyo